Bachem Holding AG
Bachem Holding AG, a leading global player in the biotechnology sector, is headquartered in Switzerland (CH) and operates extensively across Europe, North America, and Asia. Founded in 1971, Bachem has established itself as a pioneer in the development and production of peptide-based active pharmaceutical ingredients (APIs) and innovative drug delivery systems. The company’s core offerings include high-quality peptides and complex organic molecules, which are distinguished by their exceptional purity and reliability. Bachem's commitment to quality and sustainability has earned it a prominent position in the pharmaceutical and biotech industries, with notable achievements in custom synthesis and contract manufacturing. As a trusted partner for major pharmaceutical companies, Bachem continues to drive advancements in therapeutic solutions, solidifying its reputation as a leader in peptide chemistry.
DitchCarbon Score
How does Bachem Holding AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bachem Holding AG's score of 30 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bachem Holding AG's reported carbon emissions
Bachem Holding AG, headquartered in Switzerland, currently does not report any specific carbon emissions data for the latest year. However, the company is committed to addressing climate change through various initiatives. Bachem has made near-term climate commitments, although specific reduction targets have not been disclosed. The company is actively engaged in the Science Based Targets initiative (SBTi), indicating a commitment to align its emissions reduction strategies with climate science. As a player in the Pharmaceuticals, Biotechnology, and Life Sciences sector, Bachem is aware of the industry's environmental impact and is taking steps to mitigate it. While the company has not set a net-zero target, it remains committed to improving its sustainability practices. Bachem's climate initiatives are self-sourced, with no data cascaded from a parent or related organization. In summary, while specific emissions data is currently unavailable, Bachem Holding AG is committed to climate action and is working towards establishing a more sustainable operational framework.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bachem Holding AG is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
